vilobelimab   Click here for help

GtoPdb Ligand ID: 11346

Synonyms: CaCP-29 | Gohibic® | IFX-1
Approved drug
vilobelimab is an approved drug
Compound class: Antibody
Comment: Vilobelimab (IFX-1) is a chimeric IgG4 monoclonal antibody against the terminal complement component, anaphylatoxin C5a. It was developed for potential to treat complement mediated inflammatory diseases. Vilobelimab blocks C5a/C5aR1 signalling in subsets of myeloid-derived suppressor cells (MDSCs) and neutrophils.
Classification Click here for help
Compound class Antibody
Approved drug? Yes. EMA (2025)
International Nonproprietary Names Click here for help
INN number INN
11304 vilobelimab
Synonyms Click here for help
CaCP-29 | Gohibic® | IFX-1
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1038
Other databases
GtoPdb PubChem SID 440816715
Search PubMed clinical trials vilobelimab
Search PubMed titles vilobelimab
Search PubMed titles/abstracts vilobelimab